Fundz

Lynx Dx, Inc. reported raising $925,000 in an initial SEC Form D filing, from an offering of $2 Million

PRIVATEJan 29, 2020$925K of $2M raised

Amount Raised

$925,000

$925,000 sold, per SEC Form D (first sale Jan 29, 2020)

Round Type

Seed

Ann ArborBiotechnologyHealthcareHealth CareHealth Diagnostics

Quick answer

Lynx Dx raised $925,000 in a Seed round, dated January 29, 2020. Lynx Dx is based in Ann Arbor, Michigan, United States.

How much did Lynx Dx raise?
Lynx Dx raised $925,000 in a Seed round on January 29, 2020.
What does Lynx Dx do?
Lynx Dx is a leader in innovative diagnostic solutions, utilizing technology developed at the University of Michigan.
Where is Lynx Dx based and how big is it?
Lynx Dx is based in Ann Arbor, Michigan, United States.

Source: Fundz verified event record.

Who else raised in Healthcare and Health Diagnostics around the same time

Companies in the same sectors as Lynx Dx that raised within 45 days of this round, from Fundz verified event records.

  • Interpace Biosciences raised $47M on January 27, 2020.
  • Aclarion raised $1.4M (Seed) on March 12, 2020.
  • Verastem Oncology raised $100M on March 6, 2020.
  • Pharmazz raised $5.5M on March 3, 2020.
  • Sarepta Therapeutics raised $400M on February 28, 2020.
  • Phio Pharmaceuticals raised $1.9M on February 24, 2020.

Who to call at Lynx Dx, and when

A new round usually means Lynx Dx is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Lynx Dx raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lynx Dx, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lynx Dx. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lynx Dx

Location

Ann Arbor, Michigan, United States

About

Lynx Dx is a leader in innovative diagnostic solutions, utilizing technology developed at the University of Michigan. The company is dedicated to developing superior genomic tests to meet clear patient needs, ensuring high accuracy and efficiency. Lynx Dx aims to provide an unparalleled customer experience through its best-in-class diagnostic testing services. Their product offerings, such as MyProstateScore 2.0, focus on enhancing patient access to critical health information.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lynx Dx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Lynx Dx's next move

See what Strategic adds

Lynx Dx raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.